Home > Insider Trading > Filing (0000049071-13-000154)

Filing Details

Accession Number:: 0000049071-13-000154
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2013-11-14 11:03:05
Reporting Period:: 2011-07-29

Filing Date:: 2013-11-14
Accepted Time:: 2013-11-14 11:03:05
Original Submission Date:: 2013-05-20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
49071	Humana Inc	HUM	Hospital & Medical Service Plans (6324)	610647538

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1194004	A Frank Damelio	Pfizer Inc. 235 East 42Nd Street, 235/23/5 New York NY 10017		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Humana Common	Acquisiton	2013-05-20	2,500	$23.05	20,829	No	4	M	Direct
Humana Common	Disposition	2013-05-20	721	$79.90	20,108	No	4	F	Direct
Humana Common	Acquisiton	2011-07-29	526	$79.83	20,634	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Humana Common	Option	Disposition	2013-05-20	2,500	$0.00	2,500	$23.05

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2005-01-02	2014-01-02	No	4	M	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Amount	Remaning Holdings	Nature of Ownership
Humana Common	Stock Unit	$0.00	1,821	1,821	Direct
Humana Common	Stock Unit	$0.00	14,025	14,025	Direct
Humana Common	Stock Unit	$0.00	2,467	2,467	Direct
Humana Common	Stock Unit	$0.00	318	318	Direct
Humana Common	Restricted Stock Units	$0.00	2,026	2,026	Direct

Amount	Remaning Holdings	Nature of Ownership
1,821	1,821	Direct
14,025	14,025	Direct
2,467	2,467	Direct
318	318	Direct
2,026	2,026	Direct

Footnotes

Annual Director's fee payable in stock units, deferred at the election of the reporting person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).
Annual Director's fee payable in stock units which have been deferred at the election of the reporting person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis (over a five-year period), exempt pursuant to Rule 16(b)-3(d)(1).
Director's cash fee elected to be converted into stock units, deferred at the election of the reporting person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis (over a five-year period), exempt pursuant to Rule 16(b)-3(d)(1).
Right to buy pursuant to Humana Inc.'s 2003 Stock Incentive Plan.
Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).
Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2011 Plan. 100% of the award is vesting on 12/31/2013.
Beginning with July 2011, on each of the Company's quarterly dividend payment dates, reporting person's brokerage firm purchased additional Humana shares with the cash dividend. Inadvertantly, these nominal purchases were not reported. Reporting person had no opposite way transactions during this time. Shares purchased at prices ranging from $70.1712 to $91.2440.